May 31, 2026 by Anthony Di PizioThis Growth Stock Is Down Over 40% in 2026. Will Investors Regret Not Buying the Dip?This could be a rare opportunity to invest in a cybersecurity powerhouse at a steep discount.
May 31, 2026 by Adam LevyThe SpaceX IPO Is Weeks Away: Here's What History Says Happens After It Starts TradingSpaceX's IPO is unprecedentedly large. Here's what the biggest IPOs in history have done after trading.
May 31, 2026 by Rick Munarriz3 Earnings Reports to Watch This WeekTech bellwethers and rising retail check in this week with fresh financials.
May 31, 2026 by Reuben Gregg BrewerIs This Ultimate High‑Yield Stock Actually Going to $0?Conagra's dividend yield is 9.8%, and investors should tread with caution.
May 31, 2026 by Jonathan PoncianoWhy This $38 Million Hope Bancorp Buy Could Be a Bigger Bet on Bank ConsolidationHope Bancorp delivers a broad suite of banking and financial services to businesses and individuals across major U.S. markets.
May 31, 2026 by Marc GubertiIs Iren the Next Winner of Nvidia's Neocloud Spending Spree?This deal has bolstered investors' enthusiasm for the data center operator.
May 31, 2026 by Jonathan PoncianoKennametal Stock Is Up 50%. Here's What a $181 Million Fund Sale Could MeanKennametal delivers advanced tooling and materials for demanding industrial sectors, leveraging innovation and a global customer base.
May 31, 2026 by Jonathan PoncianoWhy This Fund Sold $35 Million of Bristow Group Amid a 40% Stock SurgeBristow Group delivers aviation and mission-critical transport services to offshore energy, government, and commercial clients worldwide.
May 31, 2026 by Anthony Di PizioThis Growth Stock Is Down Over 40% in 2026. Will Investors Regret Not Buying the Dip?This could be a rare opportunity to invest in a cybersecurity powerhouse at a steep discount.
May 31, 2026 by Adam LevyThe SpaceX IPO Is Weeks Away: Here's What History Says Happens After It Starts TradingSpaceX's IPO is unprecedentedly large. Here's what the biggest IPOs in history have done after trading.
May 31, 2026 by Alex CarchidiThis Emerging Risk Is Unlike Anything the Biotech Industry Has Ever ExperiencedBiotech companies have always licensed programs, but never so many from one region in particular.
May 31, 2026 by Kailey Hagen, CFPClaiming Social Security at 62? 4 Ways You Can Still Increase Your Future Benefits.Increasing your checks after applying is more doable than you may think.
May 31, 2026 by Rick Munarriz3 Earnings Reports to Watch This WeekTech bellwethers and rising retail check in this week with fresh financials.
May 31, 2026 by David Dierking3 Vanguard ETFs Long-Term Investors Should Consider Adding in JuneTech stocks have rebounded in a big way, but these Vanguard ETFs have strong setups heading into the second half of the year.
May 31, 2026 by Jeff SiegelNio Just Launched a Budget EV to Take On Tesla and BYD. Is Nio Stock Finally Worth Buying?Lower prices and better margins are changing the Nio story.
May 31, 2026 by Robert IzquierdoIs Gibraltar Industries Stock a Buy After the CEO Purchased Nearly 20,000 Shares?This diversified building products manufacturer attracted insider buying following a sharp one-year share price decline.
May 31, 2026 by Christy BieberHere Are the Average Social Security Benefits at the Most Popular Retirement AgesThere are certain ages when people are more likely to retire. Find out what the average benefit is at each of those ages.
May 31, 2026 by Leo SunThe Real Reason XRP Keeps Bouncing Back -- and What Comes NextHopes for bigger overseas banking partnerships are keeping the token above $1.
May 31, 2026 by Josh Kohn-LindquistFirst Trust (MISL) vs. ARK (ARKX): Which Space and Aerospace ETF Reigns Supreme?Expense ratios, sector weightings, and risk profiles set these two aerospace ETFs apart—see how their strategies shape investor outcomes.
May 31, 2026 by Brett SchaferMissed Out on Nvidia? Here's 1 AI Stock You Can Buy Right Now.This major beneficiary of artificial intelligence is flying under investors' radar today.
May 31, 2026 by Reuben Gregg BrewerCapital One's Auto Loan Trends Are Quietly Improving. Why It Matters for the Stock.Capital One tends to lend to higher-risk customers, which can be high-reward and high-risk.
May 31, 2026 by Robert IzquierdoCRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026.
May 31, 2026 by Adria Cimino7 Billionaires Just Sold Shares of This AI Giant That's Climbed 105,000% Since Its IPO. And 1 Bought the Stock. Which Should You Follow?These expert investors may offer us investing inspiration.
